Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-25-007027
Filing Date
2025-06-16
Accepted
2025-06-16 17:03:10
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3633
  Complete submission text file 0001654954-25-007027.txt   5196
Mailing Address NEOPROBE CORPORATION 425 METRO PLACE NORTH #300 DUBLIN OH 43017
Business Address
Blair Anthony K (Reporting) CIK: 0001297970 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38298 | Film No.: 251050961

Mailing Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Corp. (Issuer) CIK: 0001684144 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)